Anti-androgen treatment using bicalutamide reduced MRP4 expression in the LnCAP prostate cancer cell line and tumors from patients treated with androgen ablation pre-operatively were found to have lower levels of MRP4 expression compared to those from uncastrated prostate cancer patients. Here, ABCC4 is linked to Familial prostate cancer.